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Abstract 
Aims. Information on high risk drug use in Turkey particularly at the regional level is lacking. 
The present analysis aims at estimating high risk cannabis (HRCU) and high risk opiate use 
(HROU) in the cities of Ankara, Istanbul and Izmir. Design and Methods. Capture-recapture 
(CRC) and multiplier methods (MM) were applied based on treatment and police data 
stratified by age and gender in the years 2009 and 2010. Case definitions refer to ICD-10 
cannabis (F.12) and opiate (F.11) disorder diagnoses from out- and inpatient treatment records 
and illegal possession of these drugs as recorded by the police. Results. HRCU was estimated 
at 28,500 (8.5 per 1,000; 95%-CI: 7.3-10.3) and 33,400 (11.9 per 1,000; 95%-CI: 10.7-13.5) 
in Ankara and Izmir, respectively. Using multipliers based on CRC estimates for Izmir, 
HRCU in Istanbul was estimated up to 166,000 (18.0 per 1,000; range: 2.8-18.0). CRC 
estimates of HROU resulted in 4,800 (1.4 per 1,000; 95% CI: 0.9-1.9) in Ankara and 
multipliers based on these gave estimates up to 20,000 (2.2 per 1,000; range: 0.9-1-7) in 
Istanbul. HROU in Izmir was not estimated due to the low absolute numbers of opiate users. 
Discussion and Conclusions. While HRCU prevalence in both Ankara and Izmir was 
considerably lower in comparison to an estimate for Berlin, the rate for Istanbul was only 
slightly lower. Compared to the majority of European cities HROU in these three Turkish 
cities may be considered rather low.  
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Introduction  
It is important to epidemiologists to be able to track the numbers of substance users in an area, 
and it is essential to health and social service providers to know the numbers of problem drug 
users (PDU) for whom services will in the first place be required. Consequently, the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has established as one of its 
five Key Indicators, the estimation of the numbers of high-risk drug users (HRDU, a recent 
redefinition and renaming of the former PDU Key Indicator). Member States are expected to 
provide annual estimates of the numbers of persons involved in high-risk drug use, meaning 
“recurrent drug use that is causing actual harms (negative consequences) to the person 
(including dependence, but also other health, psychological or social problems) or is placing 
the person at a high probability/risk of suffering such harms” [1].  
 
As implemented in most countries, the HRDU indicator has tended to focus on marginalized 
heavy users of opiates. The EMCDDA has produced a series of guidelines describing 
estimation methods. These include direct methods of counting through surveys, which may be 
practicable for cannabis but are generally held to be unsuitable for substances such as opiates, 
the marginalized users of which may tend to be unreachable in conventional surveys and 
unwilling to admit to their illegal activity. Indirect methods may be required for the hard-to-
reach populations. These include multiplier methods and capture-recapture estimation from 
incomplete but overlapping lists; these methods are widely used in EU countries and affiliated 
states. The study reported in the present paper was carried out in order to apply for the first 
time methods of this kind to estimating numbers of drug users in Turkey, within the context 
of moving towards the harmonisation of information in Turkey with the European Union. 
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Previous epidemiological studies investigating substance use in Turkey have been limited 
primarily to self-reports in school and university-based surveys. Compared to EU countries, 
the available data in Turkey suggest rather low prevalence rates for any drug use, including 
cannabis [2] which appears to be the most widely used substance among school and university 
students. The rates that have been reported vary depending on the setting, study population 
and year of the survey. Lifetime prevalence rates of self-reported drug use among university 
students range between 2.3 and 6.6% [3-7]. Naturally, lower rates of any lifetime use were 
recorded among primary and secondary school students [8-10]. Beyond these studies that 
have been conducted at the regional or city level among school or university students there 
are very few referring to the general population [11;12].  
 
Estimates of drug use and drug use patterns derived from school, college or population studies 
rely on self-reports. However, as in every country, drug laws and prosecution of possession 
may result in drug users hiding this particular behaviour and not admitting it even if 
anonymity is assured. Depending on the degree of stigmatization and social exclusion of drug 
users, surveys are likely to miss this subgroup. Thus, the lack of reliable data on drug use and 
particularly on opiate use in the general population calls for the application of indirect 
methods of estimating the drug using population. The capture-recapture method (for an 
overview see [13]) employs information from various sources where drug users are registered, 
such as treatment services, police or the criminal justice system (convictions or probation). 
Registers are usually available at regional or community level. It is necessary to be able to 
identify individuals, in order to determine whether the same person appears in more than one 
register. Alternatives to capture-recapture analysis include Multiplier Methods [14]. The drug 
using population is derived by estimating what proportion of the population is hidden and 
applying this figure to the number of observed users. The present study set out to estimate the 
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numbers of high risk opiate and cannabis users in the three largest Turkish cities of Ankara, 
Istanbul and Izmir. 
 
Methods 
Data sources 
Drug-related data was requested for in- and out-patient treatment as well as for police arrests 
consisting of personal ID code, demographic information such as age, gender and region, type 
of drug use, and, for the treatment data, diagnosis of substance use disorders. Data was 
collected according to the area where the person obtained addiction treatment or was arrested, 
and was recorded at the level of provinces rather than cities. However, as the three cities are 
overwhelmingly the main population centers of their respective provinces, we will hereafter 
refer to cities rather than provinces. For reasons of data protection, personal information of 
each individual in each source was coded. The identifiers were used to determine the overlap 
between sources and were deleted once the overlap pattern had been established. The code 
used for each individual in each of the sources was forename initial, surname initial, date of 
birth and gender. For both sources information was available for the years 2009 and 2010. 
 
Case Definition 
Records on inpatient and outpatient treatment were based on ICD-10 codes indicating 
diagnoses of substance use disorders (F10-F19). Police records contained labels of the drug 
involved in the person’s arrest for drug possession. The pattern of drug use captured by the 
combination of cannabis- or opiate-related disorders and an indicator of illegal possession of 
cannabis or opiates was labelled “high risk cannabis use” (HRCU) and “high risk opiate use” 
(HROU). In this context, high risk use defines a drug-using behaviour that may eventually 
lead to health or judicial high risks. 
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Statistical Analysis 
Data were analysed using the capture-recapture method (CRC) [15]. For all analyses, data 
were stratified by age group (15-24, 25-34, and 35-64 years) and gender, and log-linear 
Poisson regression models were fitted separately to the stratified pattern of overlaps between 
the sources of data. It is not recommended to use CRC with only two sources, because it is 
then necessary to assume independence of the two sources [16]; this is an untestable and 
usually improbable assumption. For this reason, four-source analyses were carried out, 
treating each year’s data from treatment and police as a separate source. Other studies have 
also increased the effective number of sources by using the same source in different periods 
of time [17-19]. For each stratified analysis the simplest 22 models were fitted; these models 
had up to two two-way interactions between data sources. The deviance statistic, the Akaike 
Information Criterion (AIC) and the Bayesian Information Criterion (BIC) were used to 
assess how well each model fitted the data [20]. If none of these models provided a good fit, 
age categories were collapsed and analyses were repeated; in the event, this was done for all 
the analyses of females. The best fitting model was used to estimate the size of the “hidden 
population” of drug users who had not been recorded by any data source. Confidence 
intervals around these estimates were constructed by the profile likelihood method [21]. 
Confidence intervals for the totals of separate estimates across age groups and gender were 
derived by a simulation-based method [22]. 
 
For estimating the number of high risk cannabis as well as high risk opiate users in Istanbul, 
none of the models resulted in satisfactory model fit. Instead, the ratio of the number of 
estimated users to the number of “captured” users in Izmir (for cannabis) and Ankara (for 
opiates) was used as multiplier on each of the four sources [14;23]. The reason for choosing 
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Izmir instead of Ankara as an anchor for the Multiplier Method (MM) was based on Turkish 
experts’ view on drug use in the three cities. Izmir and Istanbul are both quite ‘western’ in 
outlook and it was felt appropriate to assume that a cannabis multiplier for Izmir would be 
valid for Istanbul. Conversely, opiate use was observed an issue in Ankara and Istanbul, but 
not in Izmir. Inspection of the raw data confirmed these subjective observations. Due to the 
low absolute numbers of opiate users “captured” in Izmir (Table 1), we refrained from 
estimating HROU. For calculating population rates for HRCU and HROU users per 1,000 
population, data on the numbers of 15–64 year-olds by age group and gender were obtained 
for each province for the years 2009 and 2010 from the Turkish population registry. The 
averages of the two years were taken. 
 
Table 1 
 
Results 
Estimates of the number of high risk cannabis users  
For Ankara, the Poisson log-linear model that included the interaction between the two years 
of treatment data provided an adequate fit to the data in the analysis of cannabis use in each 
age group for males and in an analysis for all females. Table 2 presents the key results. The 
estimated number of male users was 26,428 and of females 2,064, resulting in a male to 
female ratio of 13:1. The rates per 1,000 population aged 15 to 64 years were 15.8 (95% CI: 
13.5-19.3) among males, 1.2 (95% CI: 0.7-2.6) among females and 8.5 (95% CI: 7.3-10.3) 
overall. 
 
Table 2 
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The same model provided an adequate fit to the data on males in Izmir, in every age group, 
and to all females (Table 2). The number of male users was estimated at 30,140 and of 
females at 3,244, resulting in a male to female ratio of 9:1. Rates per 1,000 population were 
21.3 (95% CI: 19.2-23.6) for males, 2.3 (95% CI: 1.3-5.0) for females and 11.9 (95% CI: 
10.7-13.5) overall. 
 
For Istanbul, the model including the interaction between the two years of treatment data 
fitted only the data for males aged 35-64 years. The interaction between the two years of 
police data had to be added in order to obtain statistically acceptable fit in the other two age 
groups. However, the resulting estimates of hidden populations for both genders yielded 
implausible estimates with excessively wide confidence intervals. Instead, the multiplier 
approach based on the estimates for Izmir was applied yielding a total ranging between 
160,373 and 166,045 high risk cannabis users for the two treatment sources and between 
26,078 and 34,456 high risk cannabis users for the two police sources. Rates per 1,000 
population aged 15 to 64 years ranged between 2.8 and 18.0 depending on data source (range 
for males: 5.1-32.3; range for females: 0.5-3.4; data for genders not shown) (Table 3).  
 
Table 3 
 
Estimates of the number of high risk opiate users  
The results of the capture-recapture estimation of high-risk opiate use in Ankara are shown in 
Table 2. Only 121 female opiate users were observed, while seven times as many male users 
were identified in the four sources. In all male age groups the interaction between the two 
treatment years yielded the best model fit. In the combined female sample, it was necessary to 
use the interaction between treatment in 2009 and police in 2010. A total of 4,760 (1.4 per 
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1,000; 95% CI: 0.9-1.9) opiate users was estimated for Ankara, with 4,117 (2.5 per 1,000; 
95% CI: 2.1-3.2) male and 643 (0.4 per 1,000; 95% CI: 0.2-0.8) female users.  
 
Based on the estimates for HROU in Ankara, multipliers for each of the four data sources 
were constructed and applied as multipliers to the Istanbul data (Table 3). The estimates 
ranged between 8,204 and 20,114 high risk opiate users in total, depending on data source 
(rates per 1,000: 0.9.-2.2). The estimates for males ranged from 7,711 (1.7 per 1,000) to 
19,600 (4.2 per 1,000) and for females from 493 (0.1 per 1,000) to 2,053 (0.4 per 1,000) (data 
for genders not shown).  
 
Discussion 
To the best of our knowledge, this is the first study estimating the number of high risk 
cannabis and opiate users in major Turkish cities, namely Ankara, Istanbul and Izmir, using 
capture-recapture and multiplier methods. While the main focus of the study was on 
estimating substance use related disorders according to the ICD-10 definition, only the 
treatment data met this condition. Given the less rigorous definitions of high risk behaviour 
found in police records, we need to acknowledge that our estimates may also encompass drug 
users who do not fulfil the ICD-10 criteria of harmful use or dependence. However, expert 
opinion supports the view that subjects registered by the police because of drug use may be 
considered high risk drug users. 
 
The capture-recapture method yielded higher rates of high risk cannabis users per 1,000 
population in Izmir (11.9; 95% CI: 10.7-13.5) than in Ankara (8.5, 95% CI: 7.3-10.2). Using 
the CRC results for Izmir as anchor for estimating HRCU in Istanbul resulted in a wide range 
with a minimum mean of 2.8 and a maximum mean of 18.0 per 1,000. Applying the lower 
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and upper limits of the 95% CI of the CRC point estimate the range widened to 2.3-23.4 cases 
per 1,000. The multiplier method provided estimates for each of the four sources separately. 
Rates derived from police data (2.8-3.7 per 1,000) were much lower than those from 
treatment data (17.4-18.0 per 1,000). This is due to substantial differences between the 
numbers of individuals known to the police in Izmir and Istanbul and between individuals 
presenting for treatment in both cities. In fact, in the two younger age groups the number of 
cases known to the police in Istanbul was only slightly higher than in Izmir, while in the older 
age group and in females the absolute number of cases known to the police in Istanbul was 
even lower than in Izmir. Conversely, the number of people presenting for treatment was 
between three to five times higher in Istanbul than in Izmir. Given a 3.5 times larger 
population in Istanbul than Izmir, a much higher number of arrests for cannabis possession 
would have been expected in Istanbul. Apart from the unexpectedly low numbers of police 
arrests that clearly underestimates the true prevalence when used in the multiplier method, 
there was almost no overlap observable between individuals identified by police and 
treatment services in the two consecutive years, which led to implausible CRC estimates. 
 
Unfortunately, comparable data on high risk cannabis users are available neither in Turkey 
nor in member states of the European Union. While the EMCDDA collects prevalence and 
treatment data, estimates of HRCU using standardized methods are missing [24]. However, 
the estimates of HRCU for Ankara, Istanbul and Izmir may be compared with the results of 
the most recent study conducted in Berlin in 2012 using DSM-IV diagnoses for cannabis use 
disorders [25]. Based on survey data the estimated mean rate of 25 HRC users per 1,000 
population for Berlin was more than twice as high as the estimate for Izmir (11.9) and three 
times as high as the estimate for Ankara (8.5). Compared to the estimate for the German 
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capital, the mean rate of HRCU for Istanbul based on treatment data (18.0) was only slightly 
lower.  
 
The prevalence of high risk opiate users based on CRC was estimated at 1.4 per 1,000 (95% 
CI: 0.9-1.9) in Ankara and using Ankara as anchor for the multiplier method at between 0.9 
and 2.2 in Istanbul. Compared to the overall Turkish estimate of 0.26 per 1,000 inhabitants 
aged 15-64 years in the year 2011, the figures for Ankara and Istanbul derived from the 
present analysis were higher. Rates of high risk opiate users can also be compared to national 
estimates reported by the European Monitoring Centre for Drugs and Drug Addiction [26]. 
According to the EMCDDA, estimates of HROU at the city level vary from 2.3 in Budapest 
(in 2005) to 19.8 in Manchester (in 2006) [27]. Compared with these figures and the results 
from the most recent CRC study in Berlin with estimates ranging between 4.7 and 7.0 per 
1,000 population for the year 2010 [28], the estimates for the two Turkish cities may still be 
considered low.  
 
In order to justify the validity of the results, the assumptions that must be met in applying 
capture-recapture methods must be considered. (1) The “closed population” assumption may 
be violated if drug users begin or stop using drugs, or if they move into or out of the area that 
is being studied within that time period. The issue of starting and stopping drug use is usually 
dealt with by restricting the time period of the study. However, in the present case it was 
necessary to use two years, a longer period than usual, in order to have an adequate number of 
data sources. (2) Matching individuals through the anonymous identifiers may not have been 
free of mistakes. Cross-referencing with a reduced set of identifiers can lead to false matching 
and impact on the validity of the prevalence estimates. In each data source we found about 5% 
of persons born on January 1st which, in Turkey, is the registration date used for individuals 
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with unknown day and month of birth. A slightly overrepresentation of these cases may have 
led to more overlaps due to false positive matches. (3) The “heterogeneity” assumption 
addresses the possibility of different probabilities for individuals of appearing in a particular 
source, for example, young drug users may be less likely than older drug users to have started 
treatment and therefore appear in a treatment data source. This risk was reduced by stratifying 
samples according to age and gender. Nevertheless, recent research has examined the impact 
of possible breaches of the traditional capture-recapture assumptions, such as heterogeneity of 
capture and independence of data sources [29;30]. As all of these mechanisms may 
simultaneously impact on the overlap patterns of the data used for CRC, it can be said that 
influences lowering the overlap will generally result in overestimating the true prevalence, 
whereas increasing the overlap will result in underestimating the true prevalence. Statistics on 
drug-related deaths, although very likely subject to underreporting, suggest low numbers of 
opiate-related deaths in the three cities, which supports the findings of a low prevalence of 
high risk opiate users in Turkey [31].  
 
Due to the wide range of the presented estimates the multiplier method may be regarded as 
inaccurate and less reliable than CRC. Nevertheless, when using Ankara instead of Izmir as 
anchor for estimating HRCU in Istanbul, results turned out to be rather similar except for a 
narrower range of estimates (data available on request). We also note that changes in the 
numbers in treatment between 2009 and 2010 could indicate that the proportions in treatment 
vary across time, perhaps due to treatment being more accessible in the later year. This may 
have an impact on the assumption that a common multiplier can be used across different time 
periods and also across different geographical areas. Table 3 does, however, suggest that a 
treatment multiplier produces consistent estimates across years in Istanbul. For estimating 
high risk drug use in other Turkish cities alternative indirect methods such as synthetic 
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estimation could have been used [32]. Unfortunately, the three cities are too few and not 
suitable for a geographical representation of urban areas in Turkey. Respondent driven 
sampling (RDS) [33] has been found efficient and effective for investigating drug-using 
populations. Recent developments [34] provide a method for estimating population size and 
hence drug use prevalence from RDS data, although this is still relatively untested. However, 
in contrast to our use of existing administrative data for CRC estimation, RDS requires 
special studies, which are unlikely to be feasible on a large scale. 
 
The main limitations of the study refer to the reliability and validity of the register data, which 
were not collected for the present purpose of estimating the number of high risk drug users. 
Addiction treatment in Turkey is usually provided in specialized centres established in large 
governmental mental hospitals. In most cases inpatient treatment is limited to only 
detoxification. In some of these treatment centres a 4-week program including group therapies 
and recreational groups is provided in addition to medical management. Due to lack of 
addiction treatment professionals, outpatient treatment available in governmental hospitals is 
limited to only medical management. There are a few small private hospitals that provide 
addiction treatment, but long term rehabilitation or residential treatment is not available [31]. 
Also the wide variation in the number of drug users arrested by the police over the years and 
across cities raises questions regarding the validity of the data. It is unclear whether this 
variation resulted from differences in police activities, changes over time, or errors in or lack 
of reporting, or whether it reflects differences in drug using behaviour. More research is 
needed to understand the data collection mechanisms. 
 
Nonetheless, despite these limitations, the present analysis yielded for the first time estimates 
of the scale of high risk drug cannabis and opiate use in three major Turkish cities using 
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capture-recapture and multiplier methods. It demonstrates the feasibility of these approaches 
and calls for further activities in the monitoring of drug use. Future studies will be necessary 
to validate these initial estimates. 
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Table 1: Number of individuals recorded in each data source by year of registration, drug 
used, age and gender. 
Ankara Year Cannabis Opiates 
Males Females Males Females 
15-24 25-34 35-64 15-64 15-24 25-34 35-64 15-64 
Treatment 2009 60 33 20 24 42 34 34 26 
Treatment 2010 165 87 29 41 
 
229 94 47 55 
Police 2009 478 631 271 86 98 61 24 25 
Police 2010 695 673 290 78 
 
277 136 52 30 
Istanbul 15-24 25-34 35-64 15-64 15-24 25-34 35-64 15-64 
Treatment 2009 175 177 81 100 98 150 138 83 
Treatment 2010 316 221 110 96 
 
282 255 182 157 
Police 2009 1,258 1,292 403 66 81 216 353 20 
Police 2010 891 976 393 82 
 
121 210 279 23 
Izmir 15-24 25-34 35-64 15-64 15-24 25-34 35-64 15-64 
Treatment 2009 51 28 14 21 
 
3 5 5 7 
Treatment 2010 97 29 26 33 14 12 12 19 
Police 2009 1,023 1,086 587 126 0 2 7 0 
Police 2010 1,189 1,073 574 117 
 
4 20 11 0 
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Table 2: Capture-recapture estimates of the number of high-risk cannabis users in Ankara and 
Izmir, and estimates of the number of high-risk opiate users in Ankara.  
 
1) Poisson log-linear models including interaction between treatment in 2009 and 2010 
2) Poisson log-linear models including interaction between treatment in 2009 and 2010 for males, and interaction 
between treatment in 2009 and police in 2010 for females 
3) Degrees of freedom 
4) Rate per 1,000 population in the relevant age group (15-64 years for totals) 
 
Ankara 
(Cannabis) 
1)
 
Deviance 
(df 
3)
) 
Observe
d cases 
Estimated 
hidden 
population 
Total 
95% confidence 
interval 
Rate per1,000 
4)
 
Males 15-24 14.1 (9) 1,325 8,094 9,419 7,545 – 11,944 23.6 (18.9-29.9) 
Males 25-34 8.2 (9) 1,362 9,123 10,485 8,279 – 13,641 24.4 (19.3-31.8) 
Males 35-64 6.7 (9) 592 5,932 6,524 4,257 – 10,919 7.7 (5.0-12.9) 
All males  3,279 23,149 26,428 22,495 – 32,194 15.8 (13.5-19.3) 
Females 10.5 (9) 217 1,847 2,064 1,159 – 4,397 1.2 (0.7-2.6) 
Total  3,496 24,996 28,492 24,495 - 34,421 8.5 (7.3-10.3) 
Izmir 
(Cannabis) 
1)
 
      
Males 15-24 19.1 (9) 2,230 10,260 12,490 10,693 – 14,773 38.0 (32.6-45.0) 
Males 25-34 11.6 (9) 2,089 8,405 10,494 9,009 – 12,382 30.2 (25.9-35.6) 
Males 35-64 3.9 (9) 1,146 6,010 7,156 5,670 – 9,291 9.7 (7.7-12.6) 
All males  5,465 24,675 30,140 27,162 – 33,451 21.3 (19.2-23.6) 
Females 9.3 (9) 282 2,962 3,244 1,807 – 6,941 2.3 (1.3-5.0) 
Total  5,747 27,537 33,384 29,813 – 37,637 11.9 (10.7-13.5)  
Ankara 
(Opiates) 
2)
 
      
Males 15-24 9.3 (9) 574 1,468 2,042 1,660-2,557 5.1 (4.2-6.4) 
Males 25-34 9.0 (9) 287 842  1,129 830-1,592 2.6 (1.9-3.7) 
Males 35-64 11.8 (9) 141 805  946 501-1,944 1.1 (0.6-2.3) 
All males  1,002 2,115 4,117 3,428-5,430 2.5 (2.1-3.2) 
Females 12.9 (9) 121 522  643 357-1,398 0.4 (0.2-0.8) 
Total  1,123 3,637 4,760  2,973-6,188 1.4 (0.9-1.9) 
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Table 3: Multiplier estimates for high risk cannabis users in Istanbul based on capture-recapture estimates for Izmir, and estimates for high risk 
opiate users in Istanbul based on capture-recapture estimates for Ankara. 
* rate per 1,000 population in the age group 15-64 years 
 
Source Estimated number of high-risk cannabis 
users  
(multiplier CRC Izmir) 
 
 
Total 
 
Rate per 
1,000* 
Estimated number of high-risk opiate 
users  
(multiplier CRC Ankara) 
  
 
Total 
 
Rate per 
1,000* 
 
M F  
Mean  
(lower-upper) 
M F  
Mean  
(lower-upper) 
 15-24 25-34 35-64 15-64   15-24 25-34 35-64 15-64   
Treatment 2009 42,858 66,337 41,403 15,448 166,045 18.0 (14.6-23.4) 4,765 4,981 3,840 2,053 15,638 1.7 (1.2-2.7) 
Treatment 2010 40,689 79,972 30,275 9,437 160,373 17.4 (14.4-21.9) 2,515 3,063 3,663 1,835 11,076 1.2 (0.8-2.1) 
Police 2009 15,359 12,485 4,913 1,699 34,456 3.7 (3.1-4.7) 1,688 3,998 13,914 514 20,114 2.2 (1.3-4.1) 
Police 2010 9,360 9,545 4,899 2,274 26,078 2.8 (2.3-3.6) 892 1,743 5,076 493 8,204 0.9 (0.5-1.6) 
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